Nicholas has been all over the Gobeille v. Liberty Mutual case and decision, but, at STAT, Yevgeniy Feyman and I spin out one implication a bit further:
The Court’s blow to transparency doesn’t hurt everyone. Large, consolidated hospital systems, which usually provide higher-cost care, are the primary beneficiaries of price opacity. After all, if you’re the most expensive hospital in your market, why would you want that information made public?
We also explain how the decision is good for dominant insurers.
